PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för etazolate. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

16 hits

Bibliografisk träff 2016-12-14

Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model.

Jindal A, Mahesh R, Bhatt S, Pandey D.

Neurochem Int · journal article · DOI 10.1016/j.neuint.2016.12.004

Bibliografisk träff 2014-08-15

Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.

Jindal A, Mahesh R, Bhatt S.

Psychopharmacology (Berl) · research support, non-u.s. gov't; journal article · DOI 10.1007/s00213-014-3705-0

Bibliografisk träff 2014-07-17

Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials.

Jia Q, Deng Y, Qing H.

Biomed Res Int · research-article; review; journal article · DOI 10.1155/2014/837157

Bibliografisk träff 2014-04-05

Antidepressant-like effects of the phosphodiesterase-4 inhibitor etazolate and phosphodiesterase-5 inhibitor sildenafil via cyclic AMP or cyclic GMP signaling in mice.

Wang C, Zhang J, Lu Y, Lin P, Pan T, Zhao X, Liu A, Wang Q, Zhou W, Zhang HT.

Metab Brain Dis · research support, non-u.s. gov't; journal article · DOI 10.1007/s11011-014-9533-4

Bibliografisk träff 2014-01-13

Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice.

Guo J, Lin P, Zhao X, Zhang J, Wei X, Wang Q, Wang C.

Neuroscience · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuroscience.2014.01.008

Bibliografisk träff 2013-08-22

Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: modulation of hypothalamic-pituitary-adrenal axis activity and brain-derived neurotrophic factor level.

Jindal A, Mahesh R, Bhatt S.

Neurochem Int · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuint.2013.08.005

Bibliografisk träff 2013-06-01

Anxiolytic-like effect of etazolate, a type 4 phosphodiesterase inhibitor in experimental models of anxiety.

Ankur J, Mahesh R, Bhatt S.

Indian J Exp Biol · research support, non-u.s. gov't; journal article

Bibliografisk träff 2013-02-04

Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage.

Jindal A, Mahesh R, Bhatt S.

Pharmacol Biochem Behav · research support, non-u.s. gov't; journal article · DOI 10.1016/j.pbb.2013.01.020

Bibliografisk träff 2012-11-23

Etazolate, an α-secretase activator, reduces neuroinflammation and offers persistent neuroprotection following traumatic brain injury in mice.

Siopi E, Llufriu-Dabén G, Cho AH, Vidal-Lletjós S, Plotkine M, Marchand-Leroux C, Jafarian-Tehrani M.

Neuropharmacology · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuropharm.2012.11.009

Bibliografisk träff 2012-06-12

Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor--an approach using rodent behavioral antidepressant tests battery.

Jindal A, Mahesh R, Gautam B, Bhatt S, Pandey D.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2012.05.051

Bibliografisk träff 2010-03-17

Etazolate improves performance in a foraging and homing task in aged rats.

Drott J, Desire L, Drouin D, Pando M, Haun F.

Eur J Pharmacol · comparative study; journal article · DOI 10.1016/j.ejphar.2010.02.036

Bibliografisk träff 2008-07-01

Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing.

Marcade M, Bourdin J, Loiseau N, Peillon H, Rayer A, Drouin D, Schweighoffer F, Désiré L.

J Neurochem · journal article · DOI 10.1111/j.1471-4159.2008.05396.x

Bibliografisk träff 1983-05-01

Anxioselective anxiolytics.

Williams M.

J Med Chem · review; journal article · DOI 10.1021/jm00359a001

Bibliografisk träff 1983-04-01

Etazolate (SQ20009): electrophysiology and effects on [3H]flunitrazepam binding in cultured cortical neurons.

Barnes DM, White WF, Dichter MA.

J Neurosci · other; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1523/jneurosci.03-04-00762.1983

Bibliografisk träff 1980-03-01

Interaction of SQ 20009 and GABA-like drugs as modulators of benzodiazepine receptor binding.

Supavilai P, Karobath M.

Eur J Pharmacol · journal article · DOI 10.1016/0014-2999(80)90282-4

Bibliografisk träff 1979-02-01

Enhancement of the binding of 3H-diazepam to rat brain membranes in vitro by SQ 20009, A novel anxiolytic, gamma-aminobutyric acid (GABA) and muscimol.

Williams M, Risley EA.

Life Sci · journal article · DOI 10.1016/0024-3205(79)90367-9